MedPath

Unravelling The Optimisation And Consolidation Of Motor Skills In People With Multiple Sclerosis With Mild to Moderate Gait Impairment: A Feasibility Study

Not Applicable
Recruiting
Conditions
Multiple Sclerosis
Registration Number
NCT07058870
Lead Sponsor
University Hospital of Ferrara
Brief Summary

The goal of this feasibility study is to test the safety and effectiveness of an high-intensity task oriented circuit training program, followed by three months of telerehabilitation in people with mild to moderate Multiple Sclerosis (MS). The main questions it aims to answer are:

* Can high-intensity task oriented circuit training improve gait and balance functional capacity?

* Can telerehabilitation mantain the benefits in gait and balance gained via circuit training for a six month period?

Participants will:

* Complete 10 session ( one hour each, three times a week) of high-intensity task oriented circuit training administered in a hospital setting. The training will target key motor skills such as walking, stepping, supine to stand transitions and general mobility.

* Engage in 3 months of asynchronous telerehabilitation (without physiotherapist supervision)

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
18
Inclusion Criteria
  • Diagnosis of primary or secondary progressive multiple sclerosis according to the McDonald criteria.
  • Mini-Mental State Examination (MMSE) score > 24.
  • Expanded Disability Status Scale (EDSS) score ≤ 6.
Exclusion Criteria
  • Presence of other psychiatric or neurological disorders.
  • Cardiopulmonary, renal, or liver diseases.
  • Pregnancy.
  • Modifications in drug treatment within the last 3 months.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Change in BalanceBaseline testing (T0), score changes after the 4 weeks in-hospital treatment (T1), score changes after the 3-months asynchronous telerehabilitation intervention (T1) and score changes at follow up, 3 months after telerehabilitation intervetion (T3)

The change in balance will be assessed using the Fullerton Advanced Balance Scale

Secondary Outcome Measures
NameTimeMethod
Change in mobility, balance, walking ability, and fall riskBaseline testing (T0), score changes after the 4 weeks in-hospital treatment (T1), score changes after the 3-months asynchronous telerehabilitation intervention (T1) and score changes at follow up, 3 months after telerehabilitation intervetion (T3)

Mobility, balance, walking ability, and fall risk will be assessed through Timed Up and Go Test

Change in Dual task CostBaseline testing (T0), score changes after the 4 weeks in-hospital treatment (T1), score changes after the 3-months asynchronous telerehabilitation intervention (T1) and score changes at follow up, 3 months after telerehabilitation intervetion (T3)

Dual Task Cost will be assessed by the difference between Timed Up and Go and Dual Task Timed Up and Go

Change in quantitative mobility and leg function performanceBaseline testing (T0), score changes after the 4 weeks in-hospital treatment (T1), score changes after the 3-months asynchronous telerehabilitation intervention (T1) and score changes at follow up, 3 months after telerehabilitation intervetion (T3)

Leg function performance and quantitative mobility assessed through Timed 25 Foot Walk

Change in auditory information processing speed and flexibilityBaseline testing (T0), score changes after the 4 weeks in-hospital treatment (T1), score changes after the 3-months asynchronous telerehabilitation intervention (T1) and score changes at follow up, 3 months after telerehabilitation intervetion (T3)

Paced Auditory Serial Addition Test will be used to assess auditory information processing speed and flexibility

Change in Walking SpeedBaseline testing (T0), score changes after the 4 weeks in-hospital treatment (T1), score changes after the 3-months asynchronous telerehabilitation intervention (T1) and score changes at follow up, 3 months after telerehabilitation intervetion (T3)

10 Meters Walking Test will be used to assess the change in walking speed

Change in ability to modify balance while walking in the presence of external demandsBaseline testing (T0), score changes after the 4 weeks in-hospital treatment (T1), score changes after the 3-months asynchronous telerehabilitation intervention (T1) and score changes at follow up, 3 months after telerehabilitation intervetion (T3)

The extended version of the Dynamic Gait Index will be used to assess ability to modify balance while walking in the presence of external demands

Change in dynamic balance during an activity requiring weight-shift and movement while in single-leg stanceBaseline testing (T0), score changes after the 4 weeks in-hospital treatment (T1), score changes after the 3-months asynchronous telerehabilitation intervention (T1) and score changes at follow up, 3 months after telerehabilitation intervetion (T3)

Step Test will be used to assess the change in dynamic balance during an activity requiring weight-shift and movement while in single-leg stance

Change in ability to transition from a supine positon to a standing position.Baseline testing (T0), score changes after the 4 weeks in-hospital treatment (T1), score changes after the 3-months asynchronous telerehabilitation intervention (T1) and score changes at follow up, 3 months after telerehabilitation intervetion (T3)

The Supine To Stand Test will be used to assess the ability to transition from a supine positon to a standing position.

Change in functional lower extremity strengthBaseline testing (T0), score changes after the 4 weeks in-hospital treatment (T1), score changes after the 3-months asynchronous telerehabilitation intervention (T1) and score changes at follow up, 3 months after telerehabilitation intervetion (T3)

Five Times Sit to Stand will be used to assess functional lower extremity strength

Change in Walking capacityBaseline testing (T0), score changes after the 4 weeks in-hospital treatment (T1), score changes after the 3-months asynchronous telerehabilitation intervention (T1) and score changes at follow up, 3 months after telerehabilitation intervetion (T3)

Walking capacity will be assessed through the 6 Minute Walking Test

Change in Subjective Trait FatigueBaseline testing (T0), score changes after the 4 weeks in-hospital treatment (T1), score changes after the 3-months asynchronous telerehabilitation intervention (T1) and score changes at follow up, 3 months after telerehabilitation intervetion (T3)

Change in subjective trait fatigue will be assessed through Modified Fatigue Impact Scale

Change in impacts of multiple sclerosis in people' lifesBaseline testing (T0), score changes after the 4 weeks in-hospital treatment (T1), score changes after the 3-months asynchronous telerehabilitation intervention (T1) and score changes at follow up, 3 months after telerehabilitation intervetion (T3)

The impact of multiple sclerosis in people' lifes will be assessed through Multiple Sclerosis Impact Scale 29.

Change in balance confidenceBaseline testing (T0), score changes after the 4 weeks in-hospital treatment (T1), score changes after the 3-months asynchronous telerehabilitation intervention (T1) and score changes at follow up, 3 months after telerehabilitation intervetion (T3)

Change in balance confidence will be assessed through Activity-Specific Balance Confidence Scale.

Change in perceieved impact of MS on the individual's walking ability.Baseline testing (T0), score changes after the 4 weeks in-hospital treatment (T1), score changes after the 3-months asynchronous telerehabilitation intervention (T1) and score changes at follow up, 3 months after telerehabilitation intervetion (T3)

The 12-item Multiple Sclerosis Walking Scale (MSWS-12) will be used to measure of the impact of MS on the individual's walking ability.

Change in Walking FatigabilityBaseline testing (T0), score changes after the 4 weeks in-hospital treatment (T1), score changes after the 3-months asynchronous telerehabilitation intervention (T1) and score changes at follow up, 3 months after telerehabilitation intervetion (T3)

The Distance Walking Index will be used to assess the Change in Walking Fatigability

Trial Locations

Locations (1)

Ferrara University Hospital

🇮🇹

Ferrara, FE, Italy

Ferrara University Hospital
🇮🇹Ferrara, FE, Italy
Sofia Straudi, MD, PhD
Contact
0532238720
sofia.straudi@unife.it
Gabriele Perachiotti, PT, PhD student
Sub Investigator
Andrea Baroni, PT, PhD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.